Bourgeon Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
723,974
+363,252
| +101% | +$6.09M | 2.39% | 15 |
|
|
2025
Q1 | $5.54M | Sell |
360,722
-299,233
| -45% | -$4.6M | 1.19% | 37 |
|
|
2024
Q4 | $14.5M | Sell |
659,955
-3,366
| -0.5% | -$74.2K | 2.72% | 8 |
|
|
2024
Q3 | $12M | Sell |
663,321
-5,015
| -0.8% | -$90.4K | 2.3% | 15 |
|
|
2024
Q2 | $10.9M | Buy |
668,336
+3,244
| +0.5% | +$52.7K | 2.13% | 19 |
|
|
2024
Q1 | $9.38M | Buy |
665,092
+6,447
| +1% | +$91K | 1.84% | 22 |
|
|
2023
Q4 | $6.88M | Sell |
658,645
-2,968
| -0.4% | -$31K | 1.52% | 28 |
|
|
2023
Q3 | $6.75M | Buy |
661,613
+9,853
| +2% | +$101K | 1.58% | 29 |
|
|
2023
Q2 | $4.91M | Buy |
+651,760
| New | +$4.91M | 1.14% | 36 |
|
|
2017
Q2 | – | Sell |
-7,350
| Closed | -$236K | – | 92 |
|
|
2017
Q1 | $236K | Sell |
7,350
-48,475
| -87% | -$1.56M | 0.15% | 73 |
|
|
2016
Q4 | $2.02M | Sell |
55,825
-14,275
| -20% | -$518K | 1.27% | 32 |
|
|
2016
Q3 | $3.23M | Buy |
70,100
+3,900
| +6% | +$179K | 2.07% | 23 |
|
|
2016
Q2 | $3.33M | Buy |
66,200
+11,650
| +21% | +$585K | 2.16% | 21 |
|
|
2016
Q1 | $2.92M | Sell |
54,550
-1,600
| -3% | -$85.6K | 1.95% | 25 |
|
|
2015
Q4 | $3.69M | Buy |
56,150
+100
| +0.2% | +$6.57K | 2.37% | 16 |
|
|
2015
Q3 | $3.17M | Buy |
56,050
+4,600
| +9% | +$260K | 2.21% | 16 |
|
|
2015
Q2 | $3.04M | Sell |
51,450
-12,450
| -19% | -$736K | 1.84% | 21 |
|
|
2015
Q1 | $3.98M | Sell |
63,900
-1,300
| -2% | -$81K | 2.44% | 11 |
|
|
2014
Q4 | $3.75M | Sell |
65,200
-100
| -0.2% | -$5.75K | 2.29% | 16 |
|
|
2014
Q3 | $3.51M | Buy |
65,300
+50
| +0.1% | +$2.69K | 2.05% | 15 |
|
|
2014
Q2 | $3.42M | Buy |
65,250
+4,700
| +8% | +$246K | 1.86% | 16 |
|
|
2014
Q1 | $3.2M | Buy |
+60,550
| New | +$3.2M | 2.02% | 16 |
|